The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Febuxostat API Market Research Report 2024
Synopsis
Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity. Upon oral administration, febuxostat selectively and noncompetitively inhibits the activity of xanthine oxidase, an enzyme that converts oxypurines, including hypoxanthine and xanthine, into uric acid. By inhibiting xanthine oxidase, uric acid production is reduced and serum uric acid levels are lowered. Febuxostat may provide protection against acute renal failure caused by the excessive release of uric acid that occurs upon massive tumor cell lysis resulting from the treatment of some malignancies.
The global Febuxostat API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Febuxostat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Febuxostat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Febuxostat API include Dr. Reddy’s Laboratories Ltd., Gentec Pharmaceutical Group, Teva API, Chongqing Shenghuaxi Pharma. Co., Ltd, Zhejiang Ausun Pharmaceutical, Indoco Remedies Limited, Lupin Ltd, Waterstone Pharmaceuticals Inc. and ALP Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Febuxostat API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Febuxostat API.
Report Scope
The Febuxostat API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Febuxostat API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Febuxostat API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories Ltd.
Gentec Pharmaceutical Group
Teva API
Chongqing Shenghuaxi Pharma. Co., Ltd
Zhejiang Ausun Pharmaceutical
Indoco Remedies Limited
Lupin Ltd
Waterstone Pharmaceuticals Inc.
ALP Pharm
Chongqing Fuan Pharmaceutical
Precise Group
Vasudha Pharma Chem
Hema Pharmaceuticals Pvt. Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Febuxostat Tablets
Others
Production by Region
India
Europe
China
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Febuxostat API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Febuxostat API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Febuxostat API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity. Upon oral administration, febuxostat selectively and noncompetitively inhibits the activity of xanthine oxidase, an enzyme that converts oxypurines, including hypoxanthine and xanthine, into uric acid. By inhibiting xanthine oxidase, uric acid production is reduced and serum uric acid levels are lowered. Febuxostat may provide protection against acute renal failure caused by the excessive release of uric acid that occurs upon massive tumor cell lysis resulting from the treatment of some malignancies.
The global Febuxostat API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Febuxostat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Febuxostat API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Febuxostat API include Dr. Reddy’s Laboratories Ltd., Gentec Pharmaceutical Group, Teva API, Chongqing Shenghuaxi Pharma. Co., Ltd, Zhejiang Ausun Pharmaceutical, Indoco Remedies Limited, Lupin Ltd, Waterstone Pharmaceuticals Inc. and ALP Pharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Febuxostat API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Febuxostat API.
Report Scope
The Febuxostat API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Febuxostat API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Febuxostat API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Reddy’s Laboratories Ltd.
Gentec Pharmaceutical Group
Teva API
Chongqing Shenghuaxi Pharma. Co., Ltd
Zhejiang Ausun Pharmaceutical
Indoco Remedies Limited
Lupin Ltd
Waterstone Pharmaceuticals Inc.
ALP Pharm
Chongqing Fuan Pharmaceutical
Precise Group
Vasudha Pharma Chem
Hema Pharmaceuticals Pvt. Ltd
Segment by Type
Purity≥98%
Purity<98%
Segment by Application
Febuxostat Tablets
Others
Production by Region
India
Europe
China
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Febuxostat API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Febuxostat API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Febuxostat API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Febuxostat API Market Overview
1.1 Product Definition
1.2 Febuxostat API Segment by Type
1.2.1 Global Febuxostat API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Febuxostat API Segment by Application
1.3.1 Global Febuxostat API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Febuxostat Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Febuxostat API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Febuxostat API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Febuxostat API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Febuxostat API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Febuxostat API Production Market Share by Manufacturers (2019-2024)
2.2 Global Febuxostat API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Febuxostat API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Febuxostat API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Febuxostat API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Febuxostat API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Febuxostat API, Product Offered and Application
2.8 Global Key Manufacturers of Febuxostat API, Date of Enter into This Industry
2.9 Febuxostat API Market Competitive Situation and Trends
2.9.1 Febuxostat API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Febuxostat API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Febuxostat API Production by Region
3.1 Global Febuxostat API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Febuxostat API Production Value by Region (2019-2030)
3.2.1 Global Febuxostat API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Febuxostat API by Region (2025-2030)
3.3 Global Febuxostat API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Febuxostat API Production by Region (2019-2030)
3.4.1 Global Febuxostat API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Febuxostat API by Region (2025-2030)
3.5 Global Febuxostat API Market Price Analysis by Region (2019-2024)
3.6 Global Febuxostat API Production and Value, Year-over-Year Growth
3.6.1 India Febuxostat API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Febuxostat API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Febuxostat API Production Value Estimates and Forecasts (2019-2030)
4 Febuxostat API Consumption by Region
4.1 Global Febuxostat API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Febuxostat API Consumption by Region (2019-2030)
4.2.1 Global Febuxostat API Consumption by Region (2019-2024)
4.2.2 Global Febuxostat API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Febuxostat API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Febuxostat API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Febuxostat API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Febuxostat API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Febuxostat API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Febuxostat API Production by Type (2019-2030)
5.1.1 Global Febuxostat API Production by Type (2019-2024)
5.1.2 Global Febuxostat API Production by Type (2025-2030)
5.1.3 Global Febuxostat API Production Market Share by Type (2019-2030)
5.2 Global Febuxostat API Production Value by Type (2019-2030)
5.2.1 Global Febuxostat API Production Value by Type (2019-2024)
5.2.2 Global Febuxostat API Production Value by Type (2025-2030)
5.2.3 Global Febuxostat API Production Value Market Share by Type (2019-2030)
5.3 Global Febuxostat API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Febuxostat API Production by Application (2019-2030)
6.1.1 Global Febuxostat API Production by Application (2019-2024)
6.1.2 Global Febuxostat API Production by Application (2025-2030)
6.1.3 Global Febuxostat API Production Market Share by Application (2019-2030)
6.2 Global Febuxostat API Production Value by Application (2019-2030)
6.2.1 Global Febuxostat API Production Value by Application (2019-2024)
6.2.2 Global Febuxostat API Production Value by Application (2025-2030)
6.2.3 Global Febuxostat API Production Value Market Share by Application (2019-2030)
6.3 Global Febuxostat API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Febuxostat API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Febuxostat API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 Gentec Pharmaceutical Group
7.2.1 Gentec Pharmaceutical Group Febuxostat API Corporation Information
7.2.2 Gentec Pharmaceutical Group Febuxostat API Product Portfolio
7.2.3 Gentec Pharmaceutical Group Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Gentec Pharmaceutical Group Main Business and Markets Served
7.2.5 Gentec Pharmaceutical Group Recent Developments/Updates
7.3 Teva API
7.3.1 Teva API Febuxostat API Corporation Information
7.3.2 Teva API Febuxostat API Product Portfolio
7.3.3 Teva API Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Teva API Main Business and Markets Served
7.3.5 Teva API Recent Developments/Updates
7.4 Chongqing Shenghuaxi Pharma. Co., Ltd
7.4.1 Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Corporation Information
7.4.2 Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Product Portfolio
7.4.3 Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Chongqing Shenghuaxi Pharma. Co., Ltd Main Business and Markets Served
7.4.5 Chongqing Shenghuaxi Pharma. Co., Ltd Recent Developments/Updates
7.5 Zhejiang Ausun Pharmaceutical
7.5.1 Zhejiang Ausun Pharmaceutical Febuxostat API Corporation Information
7.5.2 Zhejiang Ausun Pharmaceutical Febuxostat API Product Portfolio
7.5.3 Zhejiang Ausun Pharmaceutical Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Zhejiang Ausun Pharmaceutical Main Business and Markets Served
7.5.5 Zhejiang Ausun Pharmaceutical Recent Developments/Updates
7.6 Indoco Remedies Limited
7.6.1 Indoco Remedies Limited Febuxostat API Corporation Information
7.6.2 Indoco Remedies Limited Febuxostat API Product Portfolio
7.6.3 Indoco Remedies Limited Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Indoco Remedies Limited Main Business and Markets Served
7.6.5 Indoco Remedies Limited Recent Developments/Updates
7.7 Lupin Ltd
7.7.1 Lupin Ltd Febuxostat API Corporation Information
7.7.2 Lupin Ltd Febuxostat API Product Portfolio
7.7.3 Lupin Ltd Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Lupin Ltd Main Business and Markets Served
7.7.5 Lupin Ltd Recent Developments/Updates
7.8 Waterstone Pharmaceuticals Inc.
7.8.1 Waterstone Pharmaceuticals Inc. Febuxostat API Corporation Information
7.8.2 Waterstone Pharmaceuticals Inc. Febuxostat API Product Portfolio
7.8.3 Waterstone Pharmaceuticals Inc. Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Waterstone Pharmaceuticals Inc. Main Business and Markets Served
7.7.5 Waterstone Pharmaceuticals Inc. Recent Developments/Updates
7.9 ALP Pharm
7.9.1 ALP Pharm Febuxostat API Corporation Information
7.9.2 ALP Pharm Febuxostat API Product Portfolio
7.9.3 ALP Pharm Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 ALP Pharm Main Business and Markets Served
7.9.5 ALP Pharm Recent Developments/Updates
7.10 Chongqing Fuan Pharmaceutical
7.10.1 Chongqing Fuan Pharmaceutical Febuxostat API Corporation Information
7.10.2 Chongqing Fuan Pharmaceutical Febuxostat API Product Portfolio
7.10.3 Chongqing Fuan Pharmaceutical Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Chongqing Fuan Pharmaceutical Main Business and Markets Served
7.10.5 Chongqing Fuan Pharmaceutical Recent Developments/Updates
7.11 Precise Group
7.11.1 Precise Group Febuxostat API Corporation Information
7.11.2 Precise Group Febuxostat API Product Portfolio
7.11.3 Precise Group Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Precise Group Main Business and Markets Served
7.11.5 Precise Group Recent Developments/Updates
7.12 Vasudha Pharma Chem
7.12.1 Vasudha Pharma Chem Febuxostat API Corporation Information
7.12.2 Vasudha Pharma Chem Febuxostat API Product Portfolio
7.12.3 Vasudha Pharma Chem Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Vasudha Pharma Chem Main Business and Markets Served
7.12.5 Vasudha Pharma Chem Recent Developments/Updates
7.13 Hema Pharmaceuticals Pvt. Ltd
7.13.1 Hema Pharmaceuticals Pvt. Ltd Febuxostat API Corporation Information
7.13.2 Hema Pharmaceuticals Pvt. Ltd Febuxostat API Product Portfolio
7.13.3 Hema Pharmaceuticals Pvt. Ltd Febuxostat API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Hema Pharmaceuticals Pvt. Ltd Main Business and Markets Served
7.13.5 Hema Pharmaceuticals Pvt. Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Febuxostat API Industry Chain Analysis
8.2 Febuxostat API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Febuxostat API Production Mode & Process
8.4 Febuxostat API Sales and Marketing
8.4.1 Febuxostat API Sales Channels
8.4.2 Febuxostat API Distributors
8.5 Febuxostat API Customers
9 Febuxostat API Market Dynamics
9.1 Febuxostat API Industry Trends
9.2 Febuxostat API Market Drivers
9.3 Febuxostat API Market Challenges
9.4 Febuxostat API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Febuxostat API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Febuxostat API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Febuxostat API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Febuxostat API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Febuxostat API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Febuxostat API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Febuxostat API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Febuxostat API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Febuxostat API as of 2023)
Table 10. Global Market Febuxostat API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Febuxostat API Production Sites and Area Served
Table 12. Manufacturers Febuxostat API Product Types
Table 13. Global Febuxostat API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Febuxostat API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Febuxostat API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Febuxostat API Production Value Market Share by Region (2019-2024)
Table 18. Global Febuxostat API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Febuxostat API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Febuxostat API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Febuxostat API Production (Ton) by Region (2019-2024)
Table 22. Global Febuxostat API Production Market Share by Region (2019-2024)
Table 23. Global Febuxostat API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Febuxostat API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Febuxostat API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Febuxostat API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Febuxostat API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Febuxostat API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Febuxostat API Consumption Market Share by Region (2019-2024)
Table 30. Global Febuxostat API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Febuxostat API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Febuxostat API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Febuxostat API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Febuxostat API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Febuxostat API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Febuxostat API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Febuxostat API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Febuxostat API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Febuxostat API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Febuxostat API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Febuxostat API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Febuxostat API Production (Ton) by Type (2019-2024)
Table 45. Global Febuxostat API Production (Ton) by Type (2025-2030)
Table 46. Global Febuxostat API Production Market Share by Type (2019-2024)
Table 47. Global Febuxostat API Production Market Share by Type (2025-2030)
Table 48. Global Febuxostat API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Febuxostat API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Febuxostat API Production Value Share by Type (2019-2024)
Table 51. Global Febuxostat API Production Value Share by Type (2025-2030)
Table 52. Global Febuxostat API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Febuxostat API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Febuxostat API Production (Ton) by Application (2019-2024)
Table 55. Global Febuxostat API Production (Ton) by Application (2025-2030)
Table 56. Global Febuxostat API Production Market Share by Application (2019-2024)
Table 57. Global Febuxostat API Production Market Share by Application (2025-2030)
Table 58. Global Febuxostat API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Febuxostat API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Febuxostat API Production Value Share by Application (2019-2024)
Table 61. Global Febuxostat API Production Value Share by Application (2025-2030)
Table 62. Global Febuxostat API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Febuxostat API Price (US$/Ton) by Application (2025-2030)
Table 64. Dr. Reddy’s Laboratories Ltd. Febuxostat API Corporation Information
Table 65. Dr. Reddy’s Laboratories Ltd. Specification and Application
Table 66. Dr. Reddy’s Laboratories Ltd. Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
Table 68. Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
Table 69. Gentec Pharmaceutical Group Febuxostat API Corporation Information
Table 70. Gentec Pharmaceutical Group Specification and Application
Table 71. Gentec Pharmaceutical Group Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Gentec Pharmaceutical Group Main Business and Markets Served
Table 73. Gentec Pharmaceutical Group Recent Developments/Updates
Table 74. Teva API Febuxostat API Corporation Information
Table 75. Teva API Specification and Application
Table 76. Teva API Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Teva API Main Business and Markets Served
Table 78. Teva API Recent Developments/Updates
Table 79. Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Corporation Information
Table 80. Chongqing Shenghuaxi Pharma. Co., Ltd Specification and Application
Table 81. Chongqing Shenghuaxi Pharma. Co., Ltd Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Chongqing Shenghuaxi Pharma. Co., Ltd Main Business and Markets Served
Table 83. Chongqing Shenghuaxi Pharma. Co., Ltd Recent Developments/Updates
Table 84. Zhejiang Ausun Pharmaceutical Febuxostat API Corporation Information
Table 85. Zhejiang Ausun Pharmaceutical Specification and Application
Table 86. Zhejiang Ausun Pharmaceutical Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Zhejiang Ausun Pharmaceutical Main Business and Markets Served
Table 88. Zhejiang Ausun Pharmaceutical Recent Developments/Updates
Table 89. Indoco Remedies Limited Febuxostat API Corporation Information
Table 90. Indoco Remedies Limited Specification and Application
Table 91. Indoco Remedies Limited Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Indoco Remedies Limited Main Business and Markets Served
Table 93. Indoco Remedies Limited Recent Developments/Updates
Table 94. Lupin Ltd Febuxostat API Corporation Information
Table 95. Lupin Ltd Specification and Application
Table 96. Lupin Ltd Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Lupin Ltd Main Business and Markets Served
Table 98. Lupin Ltd Recent Developments/Updates
Table 99. Waterstone Pharmaceuticals Inc. Febuxostat API Corporation Information
Table 100. Waterstone Pharmaceuticals Inc. Specification and Application
Table 101. Waterstone Pharmaceuticals Inc. Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Waterstone Pharmaceuticals Inc. Main Business and Markets Served
Table 103. Waterstone Pharmaceuticals Inc. Recent Developments/Updates
Table 104. ALP Pharm Febuxostat API Corporation Information
Table 105. ALP Pharm Specification and Application
Table 106. ALP Pharm Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. ALP Pharm Main Business and Markets Served
Table 108. ALP Pharm Recent Developments/Updates
Table 109. Chongqing Fuan Pharmaceutical Febuxostat API Corporation Information
Table 110. Chongqing Fuan Pharmaceutical Specification and Application
Table 111. Chongqing Fuan Pharmaceutical Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Chongqing Fuan Pharmaceutical Main Business and Markets Served
Table 113. Chongqing Fuan Pharmaceutical Recent Developments/Updates
Table 114. Precise Group Febuxostat API Corporation Information
Table 115. Precise Group Specification and Application
Table 116. Precise Group Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Precise Group Main Business and Markets Served
Table 118. Precise Group Recent Developments/Updates
Table 119. Vasudha Pharma Chem Febuxostat API Corporation Information
Table 120. Vasudha Pharma Chem Specification and Application
Table 121. Vasudha Pharma Chem Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Vasudha Pharma Chem Main Business and Markets Served
Table 123. Vasudha Pharma Chem Recent Developments/Updates
Table 124. Hema Pharmaceuticals Pvt. Ltd Febuxostat API Corporation Information
Table 125. Hema Pharmaceuticals Pvt. Ltd Specification and Application
Table 126. Hema Pharmaceuticals Pvt. Ltd Febuxostat API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Hema Pharmaceuticals Pvt. Ltd Main Business and Markets Served
Table 128. Hema Pharmaceuticals Pvt. Ltd Recent Developments/Updates
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Febuxostat API Distributors List
Table 132. Febuxostat API Customers List
Table 133. Febuxostat API Market Trends
Table 134. Febuxostat API Market Drivers
Table 135. Febuxostat API Market Challenges
Table 136. Febuxostat API Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Febuxostat API
Figure 2. Global Febuxostat API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Febuxostat API Market Share by Type: 2023 VS 2030
Figure 4. Purity≥98% Product Picture
Figure 5. Purity<98% Product Picture
Figure 6. Global Febuxostat API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Febuxostat API Market Share by Application: 2023 VS 2030
Figure 8. Febuxostat Tablets
Figure 9. Others
Figure 10. Global Febuxostat API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Febuxostat API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Febuxostat API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Febuxostat API Production (Ton) & (2019-2030)
Figure 14. Global Febuxostat API Average Price (US$/Ton) & (2019-2030)
Figure 15. Febuxostat API Report Years Considered
Figure 16. Febuxostat API Production Share by Manufacturers in 2023
Figure 17. Febuxostat API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Febuxostat API Revenue in 2023
Figure 19. Global Febuxostat API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Febuxostat API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Febuxostat API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Febuxostat API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. India Febuxostat API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Febuxostat API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Febuxostat API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Global Febuxostat API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 27. Global Febuxostat API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. North America Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 29. North America Febuxostat API Consumption Market Share by Country (2019-2030)
Figure 30. Canada Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 31. U.S. Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. Europe Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Febuxostat API Consumption Market Share by Country (2019-2030)
Figure 34. Germany Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 35. France Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. U.K. Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. Italy Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Russia Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Asia Pacific Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Febuxostat API Consumption Market Share by Regions (2019-2030)
Figure 41. China Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 42. Japan Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. South Korea Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. China Taiwan Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. Southeast Asia Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. India Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. Latin America, Middle East & Africa Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Febuxostat API Consumption Market Share by Country (2019-2030)
Figure 49. Mexico Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 50. Brazil Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Turkey Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. GCC Countries Febuxostat API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. Global Production Market Share of Febuxostat API by Type (2019-2030)
Figure 54. Global Production Value Market Share of Febuxostat API by Type (2019-2030)
Figure 55. Global Febuxostat API Price (US$/Ton) by Type (2019-2030)
Figure 56. Global Production Market Share of Febuxostat API by Application (2019-2030)
Figure 57. Global Production Value Market Share of Febuxostat API by Application (2019-2030)
Figure 58. Global Febuxostat API Price (US$/Ton) by Application (2019-2030)
Figure 59. Febuxostat API Value Chain
Figure 60. Febuxostat API Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
